C ognitive impairment and dementia (CID) increases the risk of disability, burden of illness, and costs.
C ognitive impairment and dementia (CID) increases the risk of disability, burden of illness, and costs. 1 CID affects about 8.6 million Americans, 2 a number expected to triple by 2050 as the Baby Boomer generation ages, 3 with higher prevalence in blacks compared with whites and in women compared with men. 4 The identification of modifiable risk factors that reduce disparities and prevent CID are top public health priorities. 5 Exciting preliminary results from the SPRINT MIND trial (Systolic Blood Pressure Intervention Trial Memory and Cognition in Decreased Hypertension) show that high blood pressure (BP) is a modifiable risk factor to reduce CID risk. 6 Although it is known that high BP, particularly in midlife, is associated with late-life CID, 7 less is known about variations by race and sex. Blacks are more likely to develop high BP and to have greater severity of high BP than whites. 8 Not only are blacks more likely to have worse BP control than whites, 9 but they also seem more likely to have detrimental brain effects from high BP. [10] [11] [12] [13] A recent study 14 suggests that blacks have greater BP-related cognitive declines, whereas, another study 15 suggests that whites do. Sex differences in the association between BP and cognitive decline are less clear. Men are more likely than women to have high BP before age 50, but this disparity narrows and reverses at older ages. A recent study 16 suggests that midlife high BP increases late-life CID risk in women, but not in men. It is uncertain whether the effect of high BP on late-life CID risk is greater in blacks than in whites or in women than in men, after accounting for the effect of age on the BP-cognition relationship. 17 We assessed the association between systolic and diastolic BP (SBP and DBP) levels, as well as levels of mean arterial pressure (MAP) and pulse pressure (PP) and cognitive trajectories, over 8 years in a large, nationally representative cohort of middle-aged and older black and white adults and tested whether race and sex modified the associations. We hypothesized that (1) higher SBP, lower DBP, and higher PP at baseline each are associated with faster cognitive decline and (2) that the effects of SBP and DBP on the slope of cognitive decline are greater in blacks compared with whites and in women compared with men.
Methods Study Design, Participants, and Measurements
Study protocol is available at http://www.regardsstudy.org. Statistical code is available through written agreement with authors from D.A. Levine. Dataset is available through a data use agreement with University of Alabama at Birmingham (email: regardsadmin@uab.edu).The REGARDS study (Reasons for Geographic and Racial Differences in Stroke) is a prospective cohort study of 30 239 non-Hispanic black and white individuals examining regional and racial influences on stroke mortality. 18 Details are described elsewhere. 18 Participants or their proxies were followed every 6 months by telephone with retrieval of medical records for reported hospitalizations. For this study, we followed participants through September 30, 2015. We required participants to have the first measurement of cognition by study design. We excluded participants with baseline cognitive impairment, defined as a Six-item Screener (SIS) score <5. 19 We also excluded participants who self-reported a baseline history of stroke or with an incident stroke before the first measurement of each cognitive outcome. The institutional review boards of all participating institutions approved the study, and all participants provided written informed consent.
Cognitive Function Assessments
Trained REGARDS interviewers administered cognitive function tests longitudinally by telephone including (1) the SIS (primary outcome; scores range, 0-6) assessed global cognition annually beginning in 2003; and (2) a battery of 3 cognitive tests (secondary outcomes) measured biennially starting in 2006 that included the Consortium to Establish a Registry for Alzheimer's Disease Word List Learning (new learning; scores range, 0-30), Word List Delayed Recall (verbal memory; scores range, 0-10), and Animal Fluency Test (executive function; scores range >0). 20, 21 These tests can be measured reliably and precisely over the telephone, [22] [23] [24] are used in Vascular Cognitive Impairment Harmonization Standards, 25 and have been validated in blacks and whites.
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Measurement of BP
At baseline, after a 5-minute rest, BP was measured twice in the left arm with a standard aneroid sphygmomanometer and the participant seated in a chair with 30 s between measurements. 27 REGARDS uses the average of the 2 BP measurements. We centered BP at 120/80 mm Hg because this was close to the mean BP for the study cohort and is considered normal BP. 28 We excluded 1 participant with an extreme value of BP (DBP ≤20; BP was 122/20) because this value is likely to be a result of incorrect measurement.
Statistical Analysis
Each outcome measure was treated as a continuous variable and analyzed separately. Linear mixed-effects models measured changes in cognitive function over time by BP and included random effects for intercept and slopes, as well as the covariates, in Table 1 . Time was expressed as the years from the date of the first measurement of each cognitive outcome. We rescaled the outcomes by dividing the cognitive scores by the SD of the distribution of the baseline cognitive measurement of each test to facilitate interpretation. For each outcome, all available cognitive observations were used in the analysis except observations after the time of first expert-adjudicated incident stroke during follow up because we have previously shown that incident stroke alters the intercept and trajectory of cognition. 29 To examine assumptions of linear mixed-effects models, for example, linearity of the studied relationships and normality of residual errors, we inspected residual plots. There was no evidence of nonlinear effects of SBP or DBP on cognitive slopes.
To test the effect of baseline BP on the slopes of cognitive trajectories (first hypothesis), model A included SBP×follow-up time and DBP×follow-up-time interaction terms, as well as SBP, DBP, follow-up time, and covariates (Table 1 and online-only Data Supplement). We examined whether age 17 and hypertension treatment status 30 modified the effect of BP level on the slopes of cognitive trajectories (eg, by investigating age×SBP×follow-up time and age×DBP×follow-up-time interaction terms). To test whether race and sex modified the effect of BP level on the slopes of cognitive trajectories (second hypothesis), model B added race×BP×follow-up time and sex×BP×follow-up-time interaction terms to model A. We stratified the data by age at baseline (45-64 versus ≥65 model years) and fitted model B for the primary outcome, SIS. The parameter estimates from the age-stratified analyses were similar to the parameter estimates from the analysis of all ages (data not shown), so we present the results from the total sample.
We also performed analyses replacing SBP and DBP with MAP ([(DBP×2)+SBP]/3) and PP (SBP-DBP). We calculated participantspecific predicted values for each cognitive score over time for an exemplar subject, for example, a 75-year old residing in the Stroke Belt with typical values of all covariates slopes of cognitive decline was estimated for 20-mm Hg differences in SBP and 10-mm Hg differences in DBP. 31 We also estimated the difference in predicted cognitive scores for different BPs (SBP, 160 versus 120 mm Hg; DBP, 60 versus 80 mm Hg) at different intervals (study time 0 versus year 8, the median follow-up time) for the exemplar subject.
Statistical significance for all analyses was set as P<0.05 (2-sided). We performed all analyses using STATA version 14.2 (Stata Corporation, College Station, TX).
Results
The study sample included 22 164 participants. Median follow-up was 8.1 years (interquartile range, 5.0-10.1 years). Follow-up time was 7.4 years in the 13 670 white participants and 6.8 years in the 8494 black participants (absolute difference, 0.63 years; 95% CI, 0.54-0.72 years; P<0.001). Follow-up time was 7.2 years in the 12 436 female participants and 7.1 years in the 9728 male participants (absolute difference, 0.05 years; 95% CI, −0.04 to 0.13 years; P=0. 3) . Figure S1 in the online-only Data Supplement presents derivation of cohort. Participants had a median of 7 SIS tests (interquartile range, 4-10 tests) and a median of two 3-test batteries (interquartile range, 2-4 tests). Because the secondary outcome Table 1 ). With increasing age, higher SBP, lower DBP, and higher PP were each associated with faster declines in global cognition. The effect of SBP and DBP on the slope of global cognition trajectories was not significantly different by hypertension treatment status (P=0.53 for hypertension treatment×SBP×follow-up-time interaction and P=0.26 for hypertension treatment×DBP×follow-up-time interaction).
In models replacing SBP and DBP with PP and MAP, PP (P<0.001), but not MAP (P=0.23), was significantly associated with changes in global cognition (model A for PP and MAP; Table 1 ). Independent of MAP, higher PP was associated with significantly faster declines in global cognition controlling for age.
Blacks had significantly faster declines in global cognition associated with SBP compared with whites (P=0.02 for race×SBP×follow-up-time interaction), but race did not modify the effect of DBP on the slope of global cognition (P=0.79 for race×DBP×follow-up-time interaction; model B for SBP and DBP; Table 1 ). Black race also modified the effect of MAP on the slope of global cognition (P=0.04 for race×MAP×follow-up-time interaction) but not the effect of PP (P=0.22 for race×PP×follow-up-time interaction; model B for PP and MAP; Table 1 ). Blacks, compared with whites, had significantly faster declines in global cognition associated with higher MAP. The effect of BP on the slope of global cognition trajectories was not significantly different by sex (P=0.23 for sex×SBP× followup-time interaction, P=0.57 for sex×DBP×follow-up-time interaction, P=0.31 for sex×PP× follow-up-time interaction, and P=0.86 for sex×MAP×follow-up-time interaction; model B for SBP/DBP and PP/MAP; Table 1 ).
We illustrate results of models B using slope estimates of global cognition changes by age, race, sex, and the 4 BP measures (SBP, DBP, PP, and MAP) and by calculating participantspecific predicted values of cognition (Table 2) Table 2 ). Figure 1 shows slopes of global cognition by SBP, race, and sex (DBP fixed at 80 mm Hg). Figure 2 shows slopes of global cognition by DBP, race, and sex (SBP fixed at 120 mm Hg). At age Interpretative key: The SIS measures global cognition (scores range 0-6). Higher scores indicate better performance. The SIS was rescaled by dividing the SIS scores by the SD of the distribution of the baseline SIS measurement. Consequently, estimates of the effects (ie, coefficients from our models) are expressed relative to the SD of the outcome at baseline. Linear mixed-effects models for a continuous included time since baseline, and baseline values of SBP, DBP, SBP×time, DBP×time, age, race, sex, age×SBP, age×DBP, race×SBP, race×DBP, current hypertension treatment, education, region, income, cigarette smoking, waist circumference, diabetes mellitus, alcohol use, depressive symptoms, self-reported health status, body mass index, age×time, race×time, age×SBP×time, age×DBP×time, and a subject-specific random intercept and slope. SBP and DBP were centered at 120 and 80 mm Hg, respectively. MAP and PP were centered at 93 and 50 mm Hg, respectively. Model A tested the hypothesis that higher SBP and lower DBP at baseline are associated with faster cognitive decline in older adults by including age×SBP and age×DBP interaction effects on the slope of global cognition. Model B tested the hypothesis that the effects of SBP and DBP on cognitive decline are greater in blacks compared with whites and in women compared with men by including race×SBP, race×DBP, sex×SBP, and sex×DBP interaction effects on the slope of global cognition. Model A for SBP and DBP is equivalent to model A for PP and MAP. Model B for SBP and DBP is equivalent to model B for PP and MAP. BP indicates blood pressure; DBP, diastolic BP; MAP, mean arterial pressure; NA, not applicable; PP, pulse pressure; REGARDS, Reasons for Geographic and Racial Differences in Stroke; SBP, systolic BP; and SIS, Six-Item Screener. 
Changes in New Learning, Verbal Memory, and Executive Function Associated With BP, Race, and Sex
Higher SBP, lower DBP, and higher PP were significantly associated with faster declines in new learning, verbal memory, and executive function in partially adjusted models that did not include the effect of age on cognitive slopes (age×follow-up-time interaction; Tables S2 and S3 ). However, the effects of SBP, DBP, and PP on the slopes of these cognitive functions did not remain significant after further adjustment for the age-by-time interaction effect except men, compared with women, had faster declines in new learning associated with SBP (P=0.04; Tables S4 and S5 ).
Sensitivity Analyses
Results were similar in analyses imputing missing values of baseline covariates, adjusting for death, adding history of These results are from model B shown in Table 1 . Participant-specific estimated changes in slopes for participants with the common values of all covariates at baseline (some college education, Stroke Belt residence, income $20 000-$34 999, never smoker, no alcohol use, no diabetes mellitus, no hypertension treatment, waist circumference 95 cm, overweight BMI, 4-item CES-D score of 0.9 points, and fair health status). Global cognition was measured by SIS. SIS scores range 0-6. SBP and DBP were centered at 120 and 80 mm Hg, respectively. Similarly, pulse pressure and mean arterial pressure were centered at 40 and 93.33 mm Hg. The SIS was rescaled by dividing the SIS scores by the SD of the distribution of the initial SIS measurement. The changes in slopes (ie, coefficients from our models) are expressed relative to the SD of the outcome at baseline. BMI indicates body mass index; CES-D, Center for Epidemiologic Studies Depression Scale; DBP, diastolic BP; MAP, mean arterial pressure; REGARDS, Reasons for Geographic and Racial Differences in Stroke; SBP, systolic BP; and SIS, Six-Item Screener. myocardial infarction and glomerular filtration rate to models, and in analyses limited to participants with ≥2 follow-up cognitive measures (Tables S6 and S9 ).
Discussion
In this national cohort of black and white Americans 45 years or older, faster declines in global cognition were associated with higher SBP, lower DBP, and higher PP in older adults. Faster declines in global cognition were associated with higher SBP and lower DBP, as well as higher PP, but not MAP. Blacks, compared with whites, had faster declines in global cognition associated with SBP and MAP. Men, compared with women, had faster declines in new learning associated with SBP. BP was not associated with slopes of verbal memory and executive function, after controlling for the effect of age on cognitive trajectories.
Our data suggest that BP-related cognitive declines are greater in blacks compared with whites and in men compared with women. Our results are consistent with a recent study 14 of older adults showing that blacks, compared with whites, have faster cognitive declines associated with high BP. Some studies have suggested that the effect of high BP on CID risk is greater in whites compared with blacks 15 and in women compared with men. 16, 32, 33 Our results may differ because we used different cognitive measures, we studied older adults, and we controlled for the age-dependent effect of BP on cognition. 17 The results of the analysis of secondary outcomes may differ from those of the SIS because the former have fewer observations, longer measurement intervals, and reduced statistical power.
The declines in global cognition associated with high SBP and low DBP in older adults are likely clinically meaningful. Declines of ≥0.5 SD from baseline have been defined as clinically meaningful decline 34 and are correlated with clinically meaningful decline in adults with normal cognition and dementia. 35, 36 A 0.5-SD decrease from the baseline score is ≈0.2 points for the SIS. The 95% CIs for the 8-year differences in global cognition for baseline SBP of 160 compared with that of 120 mm Hg for exemplar individuals aged 75 years or older include declines of this magnitude or approach them for white women (95% CI, 0.05-0.19). Declines in global cognition significantly increase the risk of death, dementia, and functional decline. 19, [37] [38] [39] High or low BP may cause cognitive decline through several mechanisms. Hypertension may cause ongoing inflammation, oxidative stress, and cerebrovascular injury. 40 Although we excluded cognitive measures occurring after the time of clinically apparent stroke, hypertension may cause subclinical vascular brain injury and damage to white matter integrity that contributes to subsequent cognitive decline. 41, 42 Hypertension may also induce or exacerbate neurodegenerative disease. 43, 44 Low BP may cause cognitive decline because of cerebral hypoperfusion. Blacks and men may be more likely to have detrimental brain effects from high BP because of early age of onset of high BP and worse BP control over the life course leading to greater arterial stiffness and more severe atherosclerosis. [10] [11] [12] [13] Our data suggest a scientific need to determine how the timing, duration, and intensity of BP lowering interventions over the life course, as well as race and sex, influence the risk of cognitive decline.
Our study has several strengths. We had longitudinal cognitive assessments in a cohort of sufficient size to estimate BP-related changes in cognitive decline and to examine potential effect modification by race, sex, age, and hypertension treatment. REGARDS systematically measured cognitive domains commonly affected by vascular factors like hypertension: global cognition, learning, memory, and executive function. 25 We had repeated measures over time up to 14 years of follow up.
Our study has limitations. Results are generalizable only to community-dwelling adults not requiring a proxy respondent. Although excluded participants had higher prevalence of dementia risk factors than included participants, these differences would reduce the ability to detect the cognitive effects of BP. BP was measured only at baseline. Although selective attrition may lead to underestimation of cognitive decline because participants with worse cognition at baseline or during follow up die, drop out, or require a proxy, analyses that accounted for loss to follow-up or death did not change our results, consistent with prior research. 45 Fewer cognitive observations potentially limited statistical power to detect associations between BP and the secondary outcomes. The slight increases in global cognition, new learning, and verbal memory over time may be because of selective attrition of cognitively impaired participants and practice effects associated with repeated testing. 46 , 47 We did not have data on functional impairments, brain imaging, daily medication use, or incident dementia.
Our study has clinical and policy implications. Preliminary results of the SPRINT MIND trial suggest that aggressive lowering of SBP reduces CID risk in older adults at high cardiovascular risk. 6 Our results extend this work by suggesting that treatment of high SBP will reduce CID risk in a broader population of older adults, particularly blacks and men. Our results also suggest that avoidance of low DBP is important to prevent cognitive decline in older adults. This is clinically important because SBP tends to increase and DBP tends to decrease as adults age. Blacks are more likely to have worse BP control than whites. Our results suggest that eliminating the black-white disparity in BP control has the potential to reduce racial disparities in CID risk. Our data also show that failure to account for the effect of age on cognitive slopes can overestimate the effect of BP on cognitive slopes and even cause a spurious association between BP and cognitive decline. Moreover, our results suggest that PP rather than MAP is a potential target for preventing CID.
Perspectives
Faster declines in global cognition over 8 years were associated with higher SBP, lower DBP, and higher PP in older adults. SBP-related cognitive declines were greater in blacks and men. Our results suggest that BP may contribute to blackwhite disparities in CID risk.
